TrialCancer immunology, immunotherapy : CII2010

WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer.

Lee M Krug et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.